Full-body MRI craze under fire: costly, inconclusive, and prone to false alarms
The piece examines neuroscientist Andrew Huberman’s endorsement of whole-body MRIs amid clinician pushback: while proponents say such scans can catch problems early, critics highlight high costs, a high rate of incidental findings, and limited evidence that these scans improve outcomes. Experts warn many findings are not actionable, risking overdiagnosis and resource strain, and that the tests are not a proven, evidence-based tool for asymptomatic individuals.
